ProstaLund investor relations material
ProstaLund AB develops and sells urological devices for the treatment of patients with benign prostatic hyperplasia (BPH) internationally. The company offers BeeVital, a non-surgical therapy for BPH. It also provides Revive Flow, a laser treatment for neurogenic bladder; and Revive Basal, a drug for neurogenic bladder. The company distributes its products in the United States, Latin America, Canada, Europe, and Australia through specialized support centers. ProstaLund is hardquartered in Lund, Sweden.